O'Shea R D, Manallack D T, Conway E L, Mercer L D, Beart P M
University of Melbourne, Clinical Pharmacology and Therapeutics, Austin Hospital, Heidelberg, Victoria, Australia.
Exp Brain Res. 1991;86(3):652-62. doi: 10.1007/BF00230539.
The possible heterogeneity of the agonist and glycine sites of the N-methyl-D-aspartate (NMDA) receptor-complex was examined using receptor binding techniques. Binding of [3H]L-glutamate [( 3H]GLU) and [3H]glycine to synaptic membranes of cerebral and cerebellar cortices, and membranes of a granule cell preparation of rat cerebellum, was characterized. [3H]Glycine always labelled a single population of sites; densities of binding sites (Bmax) in cortical, cerebellar and "granule" membranes were 3.1, 0.87 and 3.6 pmol/mg protein, respectively. Dissociation constants (Kd) in the same three preparations were 0.13, 0.31 and 1.9 microM, respectively. In competition studies, D-cycloserine, but not D-serine and 7-chlorokynurenate, showed varying potency between the membrane preparations, and analysis of variance (ANOVA) revealed a significant interaction between ligands and membrane fractions. Binding of [3H]GLU was saturable and to a single population of sites: Kd 0.5-0.9 microM and Bmax 3.2-3.6 pmol/mg protein. In all three membrane preparations the rank order of potency of NMDA agonists as inhibitors of the binding of [3H]GLU was always L-aspartate greater than L-cysteate greater than L-cysteinesulphinate greater than L-serine-O-sulphate greater than ibotenate greater than L-homocysteate. NMDA, quinolinate and competitive NMDA antagonists were only weak inhibitors of the binding of [3H]GLU and never fully inhibited specific binding. Other subtype-selective excitatory amino acids were very weak or ineffective inhibitors of binding. Binding of NMDA agonists was better described by a two site model whereby the proportion of high affinity sites did not vary significantly across the three membrane preparations.(ABSTRACT TRUNCATED AT 250 WORDS)
运用受体结合技术,研究了N-甲基-D-天冬氨酸(NMDA)受体复合物激动剂位点和甘氨酸位点可能存在的异质性。对[3H]L-谷氨酸([3H]GLU)和[3H]甘氨酸与大脑和小脑皮质突触膜以及大鼠小脑颗粒细胞制剂膜的结合进行了表征。[3H]甘氨酸始终标记单一的位点群体;皮质、小脑和“颗粒”膜中结合位点的密度(Bmax)分别为3.1、0.87和3.6 pmol/mg蛋白质。相同三种制剂中的解离常数(Kd)分别为0.13、0.31和1.9 microM。在竞争研究中,D-环丝氨酸在不同膜制剂间显示出不同的效力,而D-丝氨酸和7-氯犬尿氨酸则无此现象,方差分析(ANOVA)显示配体与膜组分之间存在显著相互作用。[3H]GLU的结合具有饱和性且针对单一的位点群体:Kd为0.5 - 0.9 microM,Bmax为3.2 - 3.6 pmol/mg蛋白质。在所有三种膜制剂中,NMDA激动剂作为[3H]GLU结合抑制剂的效力排序始终为:L-天冬氨酸>L-半胱氨酸>L-半胱氨酸亚磺酸盐>L-丝氨酸-O-硫酸盐>鹅膏蕈氨酸>L-高半胱氨酸。NMDA、喹啉酸和竞争性NMDA拮抗剂仅是[3H]GLU结合的弱抑制剂,从未完全抑制特异性结合。其他亚型选择性兴奋性氨基酸对结合的抑制作用非常弱或无效。NMDA激动剂的结合用双位点模型能更好地描述,其中高亲和力位点的比例在三种膜制剂间无显著差异。(摘要截取自250字)